Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

[Sentinel node detection using optonuclear probe (gamma and fluorescence) after green indocyanine and radio-isotope injections].

Poumellec MA, Dejode M, Figl A, Darcourt J, Haudebourg J, Sabah Y, Voury A, Martaens A, Barranger E.

Gynecol Obstet Fertil. 2016 Apr;44(4):207-10. doi: 10.1016/j.gyobfe.2016.02.012. Epub 2016 Mar 17. French.

PMID:
26997463
2.

Further data about catheter related venous thrombosis in oncology.

Marcy PY, Thariat J, Lacout A, Sanglier J, Figl A, Chamorey E.

Thromb Res. 2014 Jul;134(1):207-9. doi: 10.1016/j.thromres.2014.04.003. Epub 2014 Apr 13. No abstract available.

PMID:
24792955
3.

Qualitative ultrasound elastography assessment of benign thyroid nodules: Patterns and intra-observer acquisition variability.

Lacout A, Chevenet C, Thariat J, Figl A, Marcy PY.

Indian J Radiol Imaging. 2013 Oct;23(4):337-41. doi: 10.4103/0971-3026.125612.

4.

External jugular vein cross-over as a new technique for percutaneous central venous port access in case of left central venous occlusion.

Marcy PY, El Hajjam M, Lacout A, Nöel C, Simon JJ, Figl A.

J Vasc Access. 2013 Oct-Dec;14(4):388-91. doi: 10.5301/jva.5000162. Epub 2013 Jul 1.

PMID:
23817955
5.

Further data about upper extremity venous ports.

Marcy PY, Lacout A, Figl A.

AJR Am J Roentgenol. 2013 Jul;201(1):W160. doi: 10.2214/AJR.12.10273. No abstract available.

PMID:
23789691
6.

Autologous fat grafting and breast cancer recurrences: retrospective analysis of a series of 100 procedures in 64 patients.

Ihrai T, Georgiou C, Machiavello JC, Chignon-Sicard B, Figl A, Raoust I, Bourgeon Y, Fouche Y, Flipo B.

J Plast Surg Hand Surg. 2013 Sep;47(4):273-5. doi: 10.3109/2000656X.2012.759583. Epub 2013 Apr 30.

PMID:
23627644
7.

TERT promoter mutations in familial and sporadic melanoma.

Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K, Schadendorf D, Kumar R.

Science. 2013 Feb 22;339(6122):959-61. doi: 10.1126/science.1230062. Epub 2013 Jan 24.

8.

Skin examination behavior: the role of melanoma history, skin type, psychosocial factors, and region of residence in determining clinical and self-conducted skin examination.

Kasparian NA, Bränström R, Chang YM, Affleck P, Aspinwall LG, Tibben A, Azizi E, Baron-Epel O, Battistuzzi L, Bruno W, Chan M, Cuellar F, Debniak T, Pjanova D, Ertmanski S, Figl A, Gonzalez M, Hayward NK, Hocevar M, Kanetsky PA, Leachman S, Bergman W, Heisele O, Palmer J, Peric B, Puig S, Schadendorf D, Gruis NA, Newton-Bishop J, Brandberg Y; Melanoma Genetics Consortium (GenoMEL).

Arch Dermatol. 2012 Oct;148(10):1142-51.

9.

Criteria to choose between distal or proximal venous port device insertion in HNC patients.

Marcy PY, Lacout A, Amoretti N, Figl A, Thariat J, Simon JJ.

Cardiovasc Intervent Radiol. 2013 Jun;36(3):874-5. doi: 10.1007/s00270-012-0402-4. Epub 2012 Jun 8. No abstract available.

PMID:
22678237
10.

A phase I study of UFT-oral vinorelbine in metastatic breast cancer.

Ferrero JM, Largillier R, Michel C, Amiot V, Milano G, Hébert C, Mari V, Courdi A, Figl A, Follana P, Barrière J, Chamorey E.

Oncology. 2011;81(2):73-8. doi: 10.1159/000330770. Epub 2011 Sep 30.

PMID:
21968516
11.

Re: Tips and tricks of percutaneous gastrostomy under image guidance in patients with limited access.

Marcy PY, Lacout A, Figl A, Thariat J.

Korean J Radiol. 2011 Sep-Oct;12(5):648-9; author reply 650. doi: 10.3348/kjr.2011.12.5.648. Epub 2011 Aug 24. No abstract available.

12.

Vertebral arteria lusoria: a life-threatening condition for oesophageal surgery.

Lacout A, Khalil A, Figl A, Liloku R, Marcy PY.

Surg Radiol Anat. 2012 May;34(4):381-3. doi: 10.1007/s00276-011-0867-x. Epub 2011 Sep 8.

PMID:
21901375
13.

Intra- and interobserver variability of US elastography: how does it affect quality?

Lacout A, Figl A, Thariat J, Marcy PY.

Radiology. 2011 Aug;260(2):610. doi: 10.1148/radiol.11110706. No abstract available.

PMID:
21778458
14.

Letter to the Editor re: "Outcome analysis in 3160 implantations of radiologically guided placements of totally implantable central venous port systems": observations about right internal jugular access.

Marcy PY, Lacout A, Figl A, Thariat J.

Eur Radiol. 2011 Oct;21(10):2166-7; author reply 2168. doi: 10.1007/s00330-011-2163-x. Epub 2011 May 28. No abstract available.

PMID:
21626361
15.

Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma.

Eigentler TK, Figl A, Krex D, Mohr P, Mauch C, Rass K, Bostroem A, Heese O, Koelbl O, Garbe C, Schadendorf D; Dermatologic Cooperative Oncology Group and the National Interdisciplinary Working Group on Melanoma.

Cancer. 2011 Apr 15;117(8):1697-703. doi: 10.1002/cncr.25631. Epub 2010 Nov 8.

16.

[Second conservative radiosurgical treatment for ipsilateral breast cancer recurrence].

Castelli J, Figl A, Raoust I, Lallement M, Flipo B, Ettore F, Chapelier C, Ferrero JM, Courdi A, Hannoun-Lévi JM.

Cancer Radiother. 2011 Apr;15(2):130-5. doi: 10.1016/j.canrad.2010.07.638. Epub 2010 Dec 14. French.

PMID:
21156348
17.

Highlights on subclavian vein access.

Marcy PY, Thariat J, Ianessi A, Figl A.

Cardiovasc Intervent Radiol. 2011 Feb;34(1):212-4; author reply 215-6. doi: 10.1007/s00270-010-0037-2. No abstract available.

PMID:
21136257
18.

Further data about upper extremity ports.

Marcy PY, Figl A, Amoretti N, Thariat J.

Cardiovasc Intervent Radiol. 2011 Jun;34(3):657-8; author reply 659-60. doi: 10.1007/s00270-010-9963-2. No abstract available.

PMID:
20811891
19.

Second conservative treatment for ipsilateral breast cancer recurrence using high-dose rate interstitial brachytherapy: preliminary clinical results and evaluation of patient satisfaction.

Hannoun-Levi JM, Castelli J, Plesu A, Courdi A, Raoust I, Lallement M, Flipo B, Ettore F, Chapelier C, Follana P, Ferrero JM, Figl A.

Brachytherapy. 2011 May-Jun;10(3):171-7. doi: 10.1016/j.brachy.2010.05.004. Epub 2010 Aug 4.

PMID:
20685178
20.

Predictors of sun protection behaviors and severe sunburn in an international online study.

Bränström R, Kasparian NA, Chang YM, Affleck P, Tibben A, Aspinwall LG, Azizi E, Baron-Epel O, Battistuzzi L, Bergman W, Bruno W, Chan M, Cuellar F, Debniak T, Pjanova D, Ertmanski S, Figl A, Gonzalez M, Hayward NK, Hocevar M, Kanetsky PA, Leachman SA, Heisele O, Palmer J, Peric B, Puig S, Schadendorf D, Gruis NA, Newton-Bishop J, Brandberg Y.

Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2199-210. doi: 10.1158/1055-9965.EPI-10-0196. Epub 2010 Jul 19.

21.

Single-nucleotide polymorphisms in DNA-repair genes and cutaneous melanoma.

Figl A, Scherer D, Nagore E, Bermejo JL, Botella-Estrada R, Gast A, Thirumaran RK, Planelles D, Hemminki K, Schadendorf D, Kumar R.

Mutat Res. 2010 Sep 30;702(1):8-16. doi: 10.1016/j.mrgentox.2010.06.011. Epub 2010 Jun 26.

PMID:
20601096
22.

Central and peripheral venous port catheters: evaluation of patients' satisfaction under local anesthesia.

Marcy PY, Figl A, Ianessi A, Chamorey E.

J Vasc Access. 2010 Apr-Jun;11(2):177-8; author reply 178. No abstract available.

PMID:
20574945
23.

Power injection via a venous port: a new challenge for radiologists.

Marcy PY, Thariat J, Figl A.

Rofo. 2010 Jun;182(6):536; author reply 536-7. doi: 10.1055/s-0029-1245439. Epub 2010 Jun 1. No abstract available.

PMID:
20517796
24.

Arm port implantation in cancer patients.

Marcy PY, Figl A, Amoretti N, Ianessi A.

Int J Clin Oncol. 2010 Jun;15(3):328-30. doi: 10.1007/s10147-010-0041-1. Epub 2010 Mar 2. No abstract available.

PMID:
20195679
25.

Melanoma risk factors, perceived threat and intentional tanning: an international online survey.

Bränström R, Chang YM, Kasparian N, Affleck P, Tibben A, Aspinwall LG, Azizi E, Baron-Epel O, Battistuzzi L, Bruno W, Chan M, Cuellar F, Debniak T, Pjanova D, Ertmański S, Figl A, Gonzalez M, Hayward NK, Hocevar M, Kanetsky PA, Leaf SL, van Nieuwpoort FA, Heisele O, Palmer J, Peric B, Puig S, Ruffin AD, Schadendorf D, Gruis NA, Brandberg Y, Newton-Bishop J.

Eur J Cancer Prev. 2010 May;19(3):216-26. doi: 10.1097/CEJ.0b013e3283354847.

26.

Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?

Bouwhuis MG, Gast A, Figl A, Eggermont AM, Hemminki K, Schadendorf D, Kumar R.

Cancer Immunol Immunother. 2010 Feb;59(2):303-12. doi: 10.1007/s00262-009-0751-2.

27.

Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations.

Scherer D, Nagore E, Bermejo JL, Figl A, Botella-Estrada R, Thirumaran RK, Angelini S, Hemminki K, Schadendorf D, Kumar R.

Int J Cancer. 2009 Oct 15;125(8):1868-75. doi: 10.1002/ijc.24548.

28.

Reduced IFN-gamma- and enhanced IL-4-producing CD4+ cord blood T cells are associated with a higher risk for atopic dermatitis during the first 2 yr of life.

Herberth G, Heinrich J, Röder S, Figl A, Weiss M, Diez U, Borte M, Herbarth O, Lehmann I; LISA study group.

Pediatr Allergy Immunol. 2010 Feb;21(1 Pt 1):5-13. doi: 10.1111/j.1399-3038.2009.00890.x. Epub 2009 Jun 23.

PMID:
19552791
29.

Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients.

Figl A, Scherer D, Nagore E, Bermejo JL, Dickes E, Thirumaran RK, Gast A, Hemminki K, Kumar R, Schadendorf D.

Mutat Res. 2009 Feb 10;661(1-2):78-84. doi: 10.1016/j.mrfmmm.2008.11.011. Epub 2008 Nov 27.

PMID:
19073198
30.

[First-line therapy in stage IV malignant melanoma].

Figl A.

J Dtsch Dermatol Ges. 2007 Aug;5(8):725. German. No abstract available.

PMID:
17659050
31.

Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.

Figl A, Thirumaran RK, Ugurel S, Gast A, Hemminki K, Kumar R, Schadendorf D.

Arch Dermatol. 2007 Apr;143(4):495-9.

PMID:
17438182
32.

Mutations linked to autosomal dominant nocturnal frontal lobe epilepsy affect allosteric Ca2+ activation of the alpha 4 beta 2 nicotinic acetylcholine receptor.

Rodrigues-Pinguet NO, Pinguet TJ, Figl A, Lester HA, Cohen BN.

Mol Pharmacol. 2005 Aug;68(2):487-501. Epub 2005 May 18.

PMID:
15901849
33.

Five ADNFLE mutations reduce the Ca2+ dependence of the mammalian alpha4beta2 acetylcholine response.

Rodrigues-Pinguet N, Jia L, Li M, Figl A, Klaassen A, Truong A, Lester HA, Cohen BN.

J Physiol. 2003 Jul 1;550(Pt 1):11-26. Epub 2003 May 16.

34.
35.

Pharmacological similarities between native brain and heterologously expressed alpha4beta2 nicotinic receptors.

Shafaee N, Houng M, Truong A, Viseshakul N, Figl A, Sandhu S, Forsayeth JR, Dwoskin LP, Crooks PA, Cohen BN.

Br J Pharmacol. 1999 Nov;128(6):1291-9.

36.

Two mutations linked to nocturnal frontal lobe epilepsy cause use-dependent potentiation of the nicotinic ACh response.

Figl A, Viseshakul N, Shafaee N, Forsayeth J, Cohen BN.

J Physiol. 1998 Dec 15;513 ( Pt 3):655-70.

37.

The alpha4 subunit of rat alpha4beta2 nicotinic receptors is phosphorylated in vivo.

Viseshakul N, Figl A, Lytle C, Cohen BN.

Brain Res Mol Brain Res. 1998 Aug 15;59(1):100-4.

PMID:
9729306
38.

Two domains of the beta subunit of neuronal nicotinic acetylcholine receptors contribute to the affinity of substance P.

Stafford GA, Oswald RE, Figl A, Cohen BN, Weiland GA.

J Pharmacol Exp Ther. 1998 Aug;286(2):619-26.

PMID:
9694912
39.

Voltage-jump relaxation kinetics for wild-type and chimeric beta subunits of neuronal nicotinic receptors.

Figl A, Labarca C, Davidson N, Lester HA, Cohen BN.

J Gen Physiol. 1996 Mar;107(3):369-79.

41.

[Reconstructive problems after radical vulvectomy in carcinoma: current trends].

Tateo A, Garassino E, Tateo S, Figl A.

Minerva Ginecol. 1994 May;46(5):257-63. Italian.

PMID:
7936375
42.

Slow and incomplete inactivations of voltage-gated channels dominate encoding in synthetic neurons.

Hsu H, Huang E, Yang XC, Karschin A, Labarca C, Figl A, Ho B, Davidson N, Lester HA.

Biophys J. 1993 Sep;65(3):1196-206.

43.

Regions of beta 4.beta 2 subunit chimeras that contribute to the agonist selectivity of neuronal nicotinic receptors.

Figl A, Cohen BN, Quick MW, Davidson N, Lester HA.

FEBS Lett. 1992 Aug 24;308(3):245-8.

Supplemental Content

Support Center